Armata Pharmaceuticals, Inc. (ARMP)
ASE · Healthcare · Biotechnology
$5.38
+2.87%
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
Market Cap
$200.0M
Shares Outstanding
37.2M
Exchange
ASE
Currency
USD
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | |
| Operating Income | (7.8M) | (8.4M) | (8.8M) | |
| Net Income | (26.7M) | (124.3M) | (115.3M) | |
| Diluted EPS | $-0.74 | N/A | $-3.16 | $-0.27 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (36.9M) | (40.9M) | (42.4M) | (31.2M) |
| Net Income | (36.9M) | (69.0M) | (18.9M) | (173.8M) |
| Diluted EPS | $-1.08 | $-1.91 | $-0.89 | $-4.80 |